Loading clinical trials...
Loading clinical trials...
A Phase 2 Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma at Stanford University
Conditions
Interventions
Sorafenib
Locations
1
United States
Stanford University School of Medicine
Stanford, California, United States
Start Date
December 1, 2007
Primary Completion Date
July 1, 2009
Completion Date
January 1, 2011
Last Updated
June 19, 2015
NCT07485114
NCT00026884
NCT07241390
NCT04634916
NCT06926660
NCT07271186
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions